Company News

A new chapter in Pakistan’s regulatory landscape was marked with the official launch of DRAP’s Digitalization Initiative, held in July 2025. The initiative signifies a transformational shift from traditional, paper-based systems to a structured, transparent, and data-driven regulatory process.

The digital transformation aims to streamline the evaluation, approval, and post-market monitoring of therapeutic goods including biologics, vaccines, life-saving drugs, and medical devices.

Key Highlights of the discussion:

• Provides digital audit trails for traceability

• Enables real-time monitoring of adverse events

• Minimizes manual errors and regulatory bias

• Strengthens regulatory communication and oversight

• Enhances trust and safety in the system through data-backed decisions

This initiative not only increases operational efficiency but also represents a cultural shift in regulatory governance, where data integrity, transparency, and scientific evidence guide public health decisions. It reflects DRAP’s vision to align with global regulatory best practices.

The event was attended by key stakeholders, including the CEO of Briogene Pvt. Ltd, showing industry support for this national step toward modernization. DRAP’s Digitalization Initiative has set the foundation for a future where regulatory processes in Pakistan are faster, smarter, and more accountable.